Burning mouth syndrome: A review of recent literature topical collection on uncommon headache syndromes

Current Pain and Headache Reports

Volumn 17, Issue 6, 2013, Pages

  Charleston IV, Larry ^a  

^a UCNS Certified Headache Medicine   (United States)

Author keywords

Atypical Facial Pain; Burning Lips; Burning Mouth; Burning Mouth Syndrome; Burning Mouth Syndrome Pathophysiology; Burning Mouth Syndrome Treatment; Dental Pain; Dry Mouth; Mouth Burning; Sore Tongue; Tongue Burning; Uncommon Headache Disorder

Indexed keywords

AMISULPRIDE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CAPSAICIN; CARBIDOPA PLUS LEVODOPA; CATUAMA; CLONAZEPAM; DIAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; DULOXETINE; GABAPENTIN; GLUTAMIC ACID; HERBACEOUS AGENT; KETAZOLAM; LAFUTIDINE; MILNACIPRAN; MOCLOBEMIDE; OLANZAPINE; PLACEBO; PRAMIPEXOLE; PREGABALIN; SEROTONIN RECEPTOR; SUCRALOSE; THIOCTIC ACID; TOPIRAMATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZINC; BENZODIAZEPINE DERIVATIVE; HISTAMINE H2 RECEPTOR ANTAGONIST; NEUROLEPTIC AGENT;

ABDOMINAL DISEASE; ACUPUNCTURE; ARTICLE; BEHAVIOR THERAPY; BURNING MOUTH SYNDROME; BURNING SENSATION; CANDIDIASIS; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG DOSE ESCALATION; DRUG MECHANISM; ELECTROCONVULSIVE THERAPY; HUMAN; LOW LEVEL LASER THERAPY; MENTAL DISEASE; MOUTH MUCOSA; NONHUMAN; PATHOGENESIS; PROTECTIVE EQUIPMENT; PSYCHOPHYSIOLOGY; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP DISORDER; TONGUE PROTECTOR; UNSPECIFIED SIDE EFFECT; FEMALE; MALE; METHODOLOGY; NERVOUS SYSTEM FUNCTION; REVIEW;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BURNING MOUTH SYNDROME; DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGONISTS; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; LASER THERAPY, LOW-LEVEL; MALE; NERVOUS SYSTEM PHYSIOLOGICAL PHENOMENA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84878731232     PISSN: 15313433     EISSN: 15343081     Source Type: Journal    
DOI: 10.1007/s11916-013-0336-9     Document Type: Article

References (69)

1. • Klasser GD, Epstein JB, Villines D. Diagnostic dilemma: the enigma of an oral burning sensation. J Can Dent Assoc. 2011;77:b146. Discusses diagnosis, prevalence, co-morbidities of burning mouth syndrome.
2. International Headache Society, Headache Classification Subcommittee. The international classification of headache disorders. 2nd ed. Cephalalgia; 2004. p. 24.
3. •• Fortuna G, Di Lorenzo M, Pollio A. Complex oral sensitivity disorder: a reappraisal of current classification of burning mouth syndrome. Oral Dis. 2013;11: [Epub ahead of print]. Reviews strengths and pitfalls of current classification and gives recommendations for classification of the BMS.
4. Forsell. H, Teerijoki-Oksa T, Kotiranta U, et al. Pain in pain behavior in burning mouth syndrome: a pain diary study. J Orofac Pain Spring. 26;117-25.
5. Hegarty AM, Zakrzewska JM. Differential diagnosis for orofacial pain, including sinusitis, TMD, trigeminal neuralgia. Dent Update. 2011;38:396-400, 402-3, 405-6.
6. Balasubramaniam R, Klasser GD, Delcanho R. Separating oral burning from burning mouth syndrome: unraveling a diagnostic enigma. Aust Dent J. 2009;54:293-9.
7. Bergdahl M, Bergdahl J. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med. 1999;28:350-4. (Pubitemid 29413876)
8. Souza FT, Santos TP, Bernardes VF, Teixeira AL, Kümmer AM, Silva TA, et al. The impact of burning mouth syndrome on health-related quality of life. Health Qual Life Outcomes. 2011;9:57.
9. •• Jääskeläinen SK. Pathophysiology of primary burning mouth syndrome. Clin Neurophysiol. 2012;123:71-7. Summarizes the recent neurophysiologic, psychophysical, neuropathological, and brain imaging evidence for neuropathic mechanisms that have been shown to play a key role in the majority of patients with primary BMS.
10. Woda A, Dao T, Gremeau-Richard C. Steroid dysregulation and stomatodynia (burning mouth syndrome). J Orofac Pain. 2009;23:202-10.
11. Liu MG, Matsuura S, Shinoda M, et al. Metabotropic glutamate receptor 5 contributes to inflammatory tongue pain via extracellular signal-regulated kinase signaling in the trigeminal spinal subnucleus caudalis and upper cervical spinal cord. J Neuroinflammation. 2012;9:258.
12. Boras VV, Savage NW, Brailo V, et al. Salivary and serum levels of substance P, neurokinin A and calcitonin gene related peptide in burning mouth syndrome. Med Oral Patol Oral Cir Bucal. 2010;15:e427-31.
13. Pezelj-Ribarić S, Kqiku L, Brumini G, et al. Proinflammatory cytokine levels in saliva in patients with burning mouth syndrome before and after treatment with low-level laser therapy. Lasers Med Sci. 2013;28:297-301.
14. Henkin RI, Gouliouk V, Fordyce A. Distinguishing patients with glossopyrosis from those with oropyrosis based upon clinical differences and differences in saliva and erythrocyte magnesium. Arch Oral Biol. 2012;57:205-10.
15. Nasri-Heir C, Gomes J, Heir GM, et al. The role of sensory input of the chorda tympani nerve and the number of fungiform papillae in burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:65-72.
16. Siviero M, Teixeira MJ, Siqueira JT, Siqueira SR. Central mechanisms in burning mouth syndrome involving the olfactory nerve: a preliminary study. Clinics. 2011;66:509-12.
17. Kaplan I, Levin T, Papoiu AD, et al. Thermal sensory and pain thresholds in the tongue and chin change with age, but are not altered in burning mouth syndrome. Skin Res Technol. 2011;17:196-200.
18. Borelli V, Zabucchi G. Burning mouth syndrome: mast cell connection. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:414.
19. Afrin LB. Burning mouth syndrome and mast cell activation disorder. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111:465-72.
20. Wandeur T, de Moura SA, de Medeiros AM, et al. Exfoliative cytology of the oral mucosa in burning mouth syndrome: a cytomorphological and cytomorphometric analysis. Gerodontology. 2011;28:44-8.
21. Sardella A, Gualerzi A, Lodi G, et al. Morphological evaluation of tongue mucosa in burning mouth syndrome. Arch Oral Biol. 2012;57:94-101.
22. Donetti E, Bedoni M, Guzzi G, et al. Burning mouth syndrome possibly linked with an amalgam tattoo: clinical and ultrastructural evidence. Eur J Dermatol. 2008;18:723-4.
23. Friedman DI. Topirimate-induced burning mouth syndrome. Headache. 2010;50:1383-5.
24. Coon EA, Laughlin RS. Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause? J Headache Pain. 2012;13:255-7.
25. Terai H, Shimahara M. Glossodynia from Candida-associated lesions, burning mouth syndrome, or mixed causes. Pain Med. 2010;11:856-60.
26. Chainani-Wu N, Madden E, Silverman Jr S. A case-control study of burning mouth syndrome and sleep dysfunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112:203-8.
27. • Kenchadze R, Iverieli M, Okribelashvili N, et al. The psychological aspects of burning mouth syndrome. Georgian Med News. 2011;194:24-8. Discusses psychological aspects of burning mouth syndrome.
28. • de Souza FT, Teixeira AL, Amaral TM, et al. Psychiatric disorders in burning mouth syndrome. J Psychosom Res. 2012;72:142-6. Summarizes psychiatric/psychological disorders in burning mouth syndrome.
29. Varvat J, Thomas-Anterion C, Decousus M, et al. Atypical Lewy body disease revealed by burning mouth syndrome and a pseudo-psychiatric syndrome. Rev Neurol. 2010;166:547-9.
30. •• Heckmann SM, Kirchner E, Grushka M, et al. A double-blind study on clonazepam in patients with burning mouth syndrome. Laryngoscope. 2012;122:813-6. Double blinded treatment trial for burning mouth syndrome.
31. Amos K, Yeoh SC, Farah CS. Combined topical and systemic clonazepam therapy for the management of burning mouth syndrome: a retrospective pilot study. J Orofac Pain. 2011;25:125-30.
32. Ko JY, Kim MJ, Lee SG, Kho HS. Outcome predictors affecting the efficacy of clonazepam therapy for the management of burning mouth syndrome (BMS). Arch Gerontol Geriatr. 2012;55:755-61.
33. Grémeau-Richard C, Dubray C, Aublet-Cuvelier B, et al. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial. Pain. 2010;149:27-32.
34. Barker KE, Batstone MD, Savage NW. Comparison of treatment modalities in burning mouth syndrome. Aust Dent J. 2009;54:300-5.
35. Silvestre-Rangil J, Silvestre FJ, Tamarit-Santafé C, Baustista D. Burning mouth syndrome: correlation of treatment to clinical variables of the disease. Med Oral Patol Oral Cir Bucal. 2011;16:e890-4.
36. •• López-D'alessandro E, Escovich L. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial. Med Oral Patol Oral Cir Bucal. 2011;16:e635-40. Double blinded treatment trial for burning mouth syndrome.
37. López V, Alonso V, Martí N, et al. Marked response of burning mouth syndrome to pregabalin treatment. Clin Exp Dermatol. 2009;34:e449-50.
38. Ueda N, Kodama Y, Hori H, et al. Two cases of burning mouth syndrome treated with olanzapine. Psychiatry Clin Neurosci. 2008;62:359-61. (Pubitemid 351832314)
39. Rodriguez-Cerdeira C, Sanchez-Blanco E. Treatment of burning mouth syndrome with amisulpride. J Clin Med Res. 2012;4:167-71.
40. Sugimoto K. The dubious effect of milnacipran for the treatment of burning mouth syndrome. Clin Neuropharmacol. 2011;34:170-3.
41. Kato Y, Sato T, Katagiri A, et al. Milnacipran dose-effect study in patients with burning mouth syndrome. Clin Neuropharmacol. 2011;34:166-9.
42. Ito M, Kimura H, Yoshida K, et al. Effectiveness of milnacipran for the treatment of chronic pain in the orofacial region. Clin Neuropharmacol. 2010;33:79-83.
43. Nagashima W, Kimura H, Ito M, et al. Effectiveness of duloxetine for the treatment of chronic nonorganic orofacial pain. Clin Neuropharmacol. 2012;35:273-7.
44. Mignogna MD, Adamo D, Schiavone V, et al. Burning mouth syndrome responsive to duloxetine: a case report. Pain Med. 2011;12:466-9.
45. Pekiner FN, Gumru B, Ozbayrak S. Efficacy of moclobemide in burning mouth syndrome: a nonrandomized, open-label study. J Orofac Pain. 2008;22:146-52.
46. Toida M, Kato K, Makita H, et al. Palliative effect of lafutidine on oral burning sensation. J Oral Pathol Med. 2009;38:262-8.
47. Stuginski-Barbosa J, Rodrigues GG, Bigal ME, Speciali JG. Burning mouth syndrome responsive to pramipexol. J Headache Pain. 2008;9:43-5.
48. Spanemberg JC, Cherubini K, de Figueiredo MA, et al. Effect of an herbal compound for treatment of burning mouth syndrome: randomized, controlled, double-blind clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;113:373-7. Double blinded treatment trial for burning mouth syndrome.
49. Cho GS, Han MW, Lee B, et al. Zinc deficiency may be a cause of burning mouth syndrome as zinc replacement therapy has therapeutic effects. J Oral Pathol Med. 2010;39:722-7.
50. Bhoopathi V, Mascarenhas AK. Zinc-replacement therapy may not reduce oral pain in patients with zinc-deficient burning mouth syndrome (BMS). J Evid Based Dent Pract. 2011;11:189-90.
51. •• Silvestre FJ, Silvestre-Rangil J, Tamarit-Santafé C, Bautista D. Application of a capsaicin rinse in the treatment of burning mouth syndrome. Med Oral Patol Oral Cir Bucal. 2012;17:e1-4. Double blinded treatment trial for burning mouth syndrome.
52. Hirsch AR, Ziad A, Kim AY, et al. Pilot study: alleviation of pain in burning mouth syndrome with topical sucralose. Headache. 2011;51:444-6.
53. •• Carbone M, Pentenero M, Carrozzo M, et al. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study. Eur J Pain. 2009;13:492-6. Double blinded treatment trial for burning mouth syndrome.
54. •• Cavalcanti DR, da Silveira FR. Alpha lipoic acid in burning mouth syndrome - a randomized double-blind placebo-controlled trial. J Oral Pathol Med. 2009;38:254-61. Double blinded treatment trial for burning mouth syndrome.
55. • López-Jornet P, Camacho-Alonso F, Leon-Espinosa S. Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study. J Oral Rehabil. 2009;36:52-7. Randomized treatment trial for burning mouth syndrome.
56. •• López-Jornet P, Camacho-Alonso F, Molino-Pagan D. Prospective, randomized, double-blind, clinical evaluation of Aloe vera Barbadensis, applied in combination with a tongue protector to treat burning mouth syndrome. J Oral Pathol Med. 2013;42(4):295-301. Double blinded treatment trial for burning mouth syndrome.
57. dos Santos LF, Carvalho Ade A, Leão JC, et al. Effect of low-level laser therapy in the treatment of burning mouth syndrome: a case series. Photomed Laser Surg. 2011;29:793-6.
58. Romeo U, Del Vecchio A, Capocci M, et al. The low level laser therapy in the management of neurological burning mouth syndrome. A pilot study. Ann Stomatol. 2010;1:14-8.
59. Kato IT, Pellegrini VD, Prates RA, et al. Low-level laser therapy in burning mouth syndrome patients: a pilot study. Photomed Laser Surg. 2010;28:835-9.
60. Yang HW, Huang YF. Treatment of burning mouth syndrome with a low-level energy diode laser. Photomed Laser Surg. 2011;29:123-5.
61. Sardella A, Lodi G, Tarozzi M, et al. Acupuncture and burning mouth syndrome: a pilot study. Pain Pract. Accessed 21 Jan 2013.
62. Scardina GA, Ruggieri A, Provenzano F, et al. Burning mouth syndrome: is acupuncture a therapeutic possibility? Br Dent J. 2010;209:E2.
63. • Yan Z, Ding N, Hua H. A systematic review of acupuncture or acupoint injection for management of burning mouth syndrome. Quintessence Int. 2012;43:695-701. A systematic review of Acupuncture/Acupoint for treatment of burning mouth syndrome.
64. Suda S, Takagai S, Inoshima-Takahashi K, et al. Electroconvulsive therapy for burning mouth syndrome. Acta Psychiatr Scand. 2008;118:503-4.
65. •• Grémeau-Richard C, Dubray C, Aublet-Cuvelier B, et al. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial. Pain. 2010;149:27-32. Double blinded crossover treatment trial for burning mouth syndrome that may have pathophysiological insights to the disorder.
66. López-Jornet P, Camacho-Alonso F, Andujar-Mateos P. A prospective, randomized study on the efficacy of tongue protector in patients with burning mouth syndrome. Oral Dis. 2011;17:277-82.
67. Kho HS, Lee JS, Lee EJ, Lee JY. The effects of parafunctional habit control and topical lubricant on discomforts associated with burning mouth syndrome (BMS). Arch Gerontol Geriatr. 2010;51:95-9.
68. Pokupec JS, Gruden V, Biocina-Lukenda D. Salivation quantum- stomatopyrosis-autogenic training. Coll Antropol. 2009;33:867-72.
69. Gruden-Pokupec JS, Gruden V, Orihovac Z. Regression analysis of the symptoms. Coll Antropol. 2009;33:143-56.